Meghan M. Fitzgerald's Insider Trades & SAST Disclosures
Meghan M. Fitzgerald's most recent trade in Tenet Healthcare Corp. was a trade of 1,551 Common Stock done . Disclosure was reported to the exchange on May 22, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Meghan M. Fitzgerald.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tenet Healthcare Corp. | Meghan M. Fitzgerald | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 1,551 | 16,820 (0%) | 0% | - | Common Stock | |
| Tenet Healthcare Corp. | Meghan M. Fitzgerald | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 1,551 | 0 | - | - | Restricted Stock Units | |
| Tenet Healthcare Corp. | Meghan M. Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 1,333 | 1,333 | - | - | Restricted Stock Units | |
| Tenet Healthcare Corp. | Meghan M. Fitzgerald | Director | Sale or transfer of securities back to the company at price $ 161.33 per share. | 22 May 2025 | 573 | 16,247 (0%) | 0% | 161.3 | 92,442 | Common Stock |
| Roivant Sciences Ltd | Meghan M. Fitzgerald | Director | Other type of transaction at price $ 12.12 per share. | 12 Sep 2024 | 894 | 29,376 | - | 12.1 | 10,835 | Common Shares |
| Roivant Sciences Ltd | Meghan M. Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2024 | 27,894 | 27,894 | - | - | Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Meghan M. Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2024 | 16,406 | 30,270 | - | 0 | Common Shares | |
| Tenet Healthcare Corp. | Meghan M. Fitzgerald | Director | Sale of securities on an exchange or to another person at price $ 146.34 per share. | 06 Aug 2024 | 20,000 | 15,269 (0%) | 0% | 146.3 | 2,926,800 | Common Stock |
| Tenet Healthcare Corp. | Meghan M. Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 1,551 | 1,551 | - | - | Restricted Stock Units | |
| Roivant Sciences Ltd | Meghan M. Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 1,261 | 13,947 | - | 0 | Common Shares | |
| Roivant Sciences Ltd | Meghan M. Fitzgerald | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.90 per share. | 24 Apr 2024 | 83 | 13,864 | - | 10.9 | 905 | Common Shares |
| Roivant Sciences Ltd | Meghan M. Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 1,328 | 12,686 | - | 0 | Common Shares | |
| Roivant Sciences Ltd | Meghan M. Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 1,152 | 1,152 | - | 0 | Common Shares | |
| Tenet Healthcare Corp. | Meghan M. Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 3,682 | 35,269 (0%) | 0% | 0 | Common Stock | |
| Roivant Sciences Ltd | Meghan M. Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2023 | 118,578 | 118,578 | - | - | Stock Option (Right to Buy) | |
| Tenet Healthcare Corp. | Meghan M. Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 3,836 | 31,587 (0%) | 0% | 0 | Common Stock | |
| Tenet Healthcare Corp. | Meghan M. Fitzgerald | Director | Sale of securities on an exchange or to another person at price $ 72.70 per share. | 16 Sep 2021 | 6,077 | 27,751 (0%) | 0% | 72.7 | 441,798 | Common Stock |
| Tenet Healthcare Corp. | Meghan M. Fitzgerald | Director | Sale of securities on an exchange or to another person at price $ 63.57 per share. | 24 May 2021 | 6,153 | 33,828 (0%) | 0% | 63.6 | 391,146 | Common Stock |
| Tenet Healthcare Corp. | Meghan M. Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 3,960 | 39,981 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges